Barrow Hanley Mewhinney & Strauss LLC Amneal Pharmaceuticals, Inc. Transaction History

Barrow Hanley Mewhinney & Strauss LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$3.36 - $6.21 $883 - $1,633	-263 Reduced 14.3%	1,576 $9,000
Q3 2023 Nov 13, 2023	SELL	$2.76 - $4.59 $430 - $716	-156 Reduced 7.82%	1,839 $7,000
Q2 2023 Aug 10, 2023	SELL	$1.33 - $3.1 $395 - $920	-297 Reduced 12.96%	1,995 $6,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $2,073 - $2,761	1,058 Added 85.74%	2,292 $4,000
Q1 2022 May 13, 2022	SELL	$3.9 - $4.89 $48,605 - $60,944	-12,463 Reduced 90.99%	1,234 $5,000
Q2 2021 Aug 12, 2021	SELL	$5.12 - $6.82 $35,102 - $46,757	-6,856 Reduced 33.36%	13,697 $70,000
Q1 2021 May 13, 2021	BUY	$4.74 - $7.38 $6,247 - $9,726	1,318 Added 6.85%	20,553 $138,000
Q4 2020 Feb 11, 2021	SELL	$3.95 - $5.42 $10,068 - $13,815	-2,549 Reduced 11.7%	19,235 $88,000
Q3 2020 Nov 12, 2020	BUY	$3.54 - $5.27 $77,115 - $114,801	21,784 New	21,784 $84,000
Q2 2020 Aug 12, 2020	SELL	$2.87 - $5.46 $321,141 - $610,952	-111,896 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.46 - $5.35 $275,264 - $598,643	111,896 New	111,896 $390,000

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Barrow Hanley Mewhinney & Strauss LLC, based on Form 13F filings with the SEC.

Stay updated on Barrow Hanley Mewhinney & Strauss LLC with notifications on news.